UNI-EN 83:ACQUISITION OF OWN SHARES
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 83 | / | 2012 | | ||||||
| Date of issue: | 2012-08-23 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| ACQUISITION OF OWN SHARES | |||||||||||
| Official market - legal basis | |||||||||||
| Inne uregulowania | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 16. August 2012 up to and including 22. August 2012 the Company bought 11650 own shares representing 0.0088% of the share capital of the Company, at a total value of BGN 28325.60 on the Bulgarian Stock Exchange. The average price per share was BGN 2.431. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 83 buy back-23082012 ENG.doc Current report 83 buy back-23082012 ENG.doc | Current report 83 buy back-23082012 ENG.doc | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2012-08-23 | Ognian Ivanov Donev | Exxecutive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
